Table 1. Comparison of baseline characteristics and laboratory measurements among the groups.
| Variable | Group 1 (PESX; n =55) | Group 2 (PEXG; n =19) | Group 3 (Control; n =48) | P-value |
|---|---|---|---|---|
| Age, years±SD | 67.9±8.1 | 70.6±7.4 | 67.3±7.6 | 0.172 |
| Gender (female/male) | 30/25 | 7/12 | 31/17 | 0.216 |
| Diabetes mellitus | 14 (25.5%) | 5 (26.3%) | 15 (31.3%) | 0.222 |
| Hypertension | 30 (54.5%) | 12 (63.2%) | 22 (45.8%) | 0.529 |
| Neutrophil count (× 103 μl)±SD | 3.52±0.80 | 3.68±0.67 | 3.16±0.91 | 0.06 |
| Lymphocyte count (× 103 μl)±SD | 1.76±0.46a | 1.72±0.31a | 2.12±0.53 | 0.002 |
| Neutrophil-to-lymphocyte ratio±SD | 2.08±0.61a | 2.20±0.58a | 1.51±0.57 | <0.001 |
Abbreviations: PEXS, pseudoexfoliation syndrome; PEXG, pseudoexfoliative glaucoma; SD, standard deviation.
a
P<0.05 in group 1 and 2 versus group 3.